KYMR
Kymera Therapeutics Inc.
$57.87
-$3.97(-6.42%)
63
Overall
60
Value
66
Tech
63
Quality
Market Cap
$4.43B
Volume
625.17K
52W Range
$19.45 - $63.96
Target Price
$67.86
EPS Estimates Overview
| Current Quarter | $-0.72 | Next Quarter | $-0.85 |
| Current Year | $-3.28 | Next Year | $-3.92 |
| QoQ Growth | -18.1% | YoY Growth | -19.5% |
| 3Y EPS CAGR | -12.6% | Target Price | $67.86 |
| Consensus | Buy | Upside | +17.3% |
EPS Historical Trend (5 Years)
Quarterly EPS Estimates
Revenue Analysis
| Current Quarter Rev | N/A | Next Quarter Rev | N/A |
| Revenue Growth | N/A | YoY Growth | N/A |
Estimates are based on analyst consensus and subject to revision. Past performance does not guarantee future results.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | KYMR | $57.87 | -6.4% | 625.17K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Kymera Therapeutics Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW